TD-5471 hydrochloride
Names
[ CAS No. ]:
530084-35-6
[ Name ]:
TD-5471 hydrochloride
[Synonym ]:
2(1H)-Quinolinone, 8-hydroxy-5-[(1R)-1-hydroxy-2-[[2-[4-[(6-methoxy[1,1'-biphenyl]-3-yl)amino]phenyl]ethyl]amino]ethyl]-, hydrochloride (1:1)
8-Hydroxy-5-{(1R)-1-hydroxy-2-[(2-{4-[(6-methoxy-3-biphenylyl)amino]phenyl}ethyl)amino]ethyl}-2(1H)-quinolinone hydrochloride (1:1)
Biological Activity
[Description]:
TD-5471 hydrochloride is a potent and selective full agonist of the human β2-adrenoceptor.
[Related Catalog]:
[Target]
β2 adrenoceptor[1]
[In Vitro]
TD-5471 is potent, with slow onset in an in vitro guinea pig trachea model. TD-5471 has potency with pEC50 of 8.7 in the guinea pig tracheal ring assay.TD-5471 is structurally differentiated from Milveterol and its long duration of action is consistent with a correlation with hydrophobicity observed in other long-acting β2-agonist discovery programs[1].
[In Vivo]
TD-5471 shows a dose-dependent and long duration of action in an in vivo guinea pig model of bronchoprotection. In a guinea pig model of in vivo bronchoprotection, TD-5471 shows excellent potency (measured 1.5 h after nebulized dosing). Because a high dose of Salmeterol (300 μg/mL) provides bronchoprotection lasting ≥24 h in this model, a 72 h time point is selected to provide confidence that TD-5471 will be suitable for once-daily dosing in man. TD-5471-mediated bronchoprotection at 72 h is dose-dependent and is significantly greater than that of Salmeterol at nebulizer concentrations of ≥30 μg/mL[1].
[References]
[Related Small Molecules]
Isoprenaline hydrochloride
|
ICI 118,551 (hydrochloride)
|
Phenylephrine hydrochloride
|
Yohimbine hydrochloride
|
Adrenaline
|
Ivabradine hydrochloride
|
Prazosin hydrochloride
|
Clenbuterol hydrochloride
|
Phentolamine mesilate
|
guanfacine hydrochloride
|
pimozide
|
Sotalol hydrochloride
|
Carvedilol
|
Atenolol
|
Metroprolol succinate
Chemical & Physical Properties
[ Molecular Formula ]:
C32H32ClN3O4
[ Molecular Weight ]:
558.067
[ Exact Mass ]:
557.208130